# Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial

Study · id `cardio:ct-nct05047198` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05047198](<https://clinicaltrials.gov/study/NCT05047198>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05047198

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 244 participants.

## Technical summary

Registry record NCT05047198. Randomized; no masking; primary purpose treatment. Start 2022-12-06 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 244 participants (planned count; ClinicalTrials.gov record NCT05047198, source copy `cardio:ctgov-nct05047198-2026-09-30`, retrieved 2026-10-26)
- Started: 2022-12-06 (actual) (ClinicalTrials.gov record NCT05047198, source copy `cardio:ctgov-nct05047198-2026-09-30`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT05047198, source copy `cardio:ctgov-nct05047198-2026-09-30`, retrieved 2026-10-26)
- Completion: 2027-12-15 (anticipated) (ClinicalTrials.gov record NCT05047198, source copy `cardio:ctgov-nct05047198-2026-09-30`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT05047198, source copy `cardio:ctgov-nct05047198-2026-09-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05047198-2026-09-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial
- Acronym: CARA-VT RCT
- Condition: Ventricular Tachycardia
- Intervention (Procedure): Control - Catheter Ablation for VT
- Intervention (Procedure): Treatment - Non-Invasive Radio Ablation for VT
- Lead sponsor: Ottawa Heart Institute Research Corporation
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Ottawa Heart Institute Research Corporation (`cardio:org-ottawa-heart-institute-research-corporation`)

## Provenance

Content hash: 050830ceed5eaa4e85fdc67e7eae3028c96e3a99b1e36ab7c83438e26d541bf5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
